Trial Profile
Pharmacokinetics bioequivalence study of KIT-302, containing a lower dosage (2.5 mg) of amlodipine
Status:
Planning
Phase of Trial:
Phase I
Latest Information Update: 27 Oct 2021
Price :
$35
*
At a glance
- Drugs Amlodipine/celecoxib (Primary)
- Indications Hypertension
- Focus Pharmacokinetics
- 19 May 2016 New trial record
- 10 May 2016 According to Kitov Pharmaceuticals media release, this study is anticipitated to be conducted by the end of 2016.